As per Pre-Diwali Dhanteras sales of gold and silver, the overall business is likely to be muted amid current high rates and subdued demand due to the COVID-19 induced economic hardship

Dalal Street today: IndusInd Bank, followed by SBI, L&T, Axis Bank, HDFC twins, Kotak Bank and ICICI Bank were among the top losers today. On the other hand, Asian Paints, Reliance Industries, Titan, Bajaj Finance and Sun Pharma were trading with gains

Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres

COVAXIN's phase-3 trial at AMU is aimed at checking the safety and effectiveness of the COVID-19 vaccine, jointly developed by the Hyderabad-headquartered Bharat Biotech, National Institute of Virology (NIV) and Indian Council of Medical Research (ICMR)

The dollar index slipped 0.09 per cent to 92.65 against a basket of six currencies

India Stock Market Highlights Today: M&M, followed by Bajaj Finance, Kotak Bank, SBI, ONGC, L&T, Tata Steel, Bajaj Finserv and Maruti were among the top gainers on Sensex pack. On the other hand, IndusInd Bank, HUL, PowerGrid, Titan and Nestle India were among the top losers today

Enough people would be vaccinated by April-May, so that the fight against the pandemic in Spain would move to another stage

Under Bingham's leadership, the taskforce has secured supply deals for more than 350 million doses of six different COVID-19 vaccine candidates, including the Pfizer shot

As coronavirus cases rise all over the world, Brazil continues to remain the third most affected country globally

India Stock Market Highlights Today: All Sensex stocks were trading in green led by ICICI Bank, Infosys, HCL Technologies, Axis Bank, HDFC Bank and Hindustan Unilever

According to Jain, aggressive testing and contact-tracing were the reasons for the high number of coronavirus cases, adding that laxity on the part of people also increased the transmission rate

India may concentrate its efforts on Bharat Biotech's Covaxin as AstraZeneca's COVID-19 vaccine deliveries may be delayed. The months of November and December could be critical in terms of vaccine availability as a number of companies are likely to publish late-stage trial data

WHO said that it would consider a draft resolution to strengthen preparedness for health emergencies through robust compliance with the International Health Regulations

The World Economic Forum (WEF) said the latest survey has shown a growing reluctance to receive a vaccine, despite progress made by numerous pharmaceutical companies working on vaccine trials

Coronavirus impact: The researchers found that there were increasing signs that coronavirus also impacts the nervous system, produces neurocognitive alterations as well as psychotic episodes

Business activity of the micro, small and medium enterprises - which are regarded as the backbone of Indian economy - is fast reaching near-normal levels; China on Tuesday said Indian and Chinese officials are in communication over India's announcement to operate more Vande Bharat Mission (VBM) flights to the country; Chief Minister Arvind Kejriwal on Wednesday said the city has seen a jump in the number of new COVID-19 cases in the last few days and it can be called a \"third wave\". Watch this and more on News Blast.Also Read: COVID-19 vaccine: Bharat Biotech's COVAXIN likely to be launched as early as February 2021

Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses

India has vaccine deals with Serum Institute of India that is manufacturing doses of the University of Oxford-AstraZeneca vaccine as well as the candidate by Novavax

Coronavirus crisis: From Thursday all non-essential shops, pubs and restaurants in England will close for four weeks, except where they serve takeaway food

Coronavirus vaccine: \"I'm optimistic that we could reach that point before the end of this year,\" Andrew Pollard said of presenting trial results this year